All > Morbid Obesity > Gabapentin

Dilaudid Injectable Product for Bariatric Surgery Candidates

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
UC Davis Health, Sacramento, CABariatric Surgery Candidates+2 MoreDilaudid Injectable Product - Drug
Eligibility
35 - 65
Female
What conditions do you have?
Select

Study Summary

This trial will study whether non-narcotic pain medications are effective in controlling pain for patients undergoing Bariatric Surgery at UC Davis Medical Center.

Eligible Conditions
  • Bariatric Surgery Candidates
  • Surgery
  • Morbid Obesity

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Similar Trials

1
SIPS Operation
3
Aminocaproic acid
1
Exparel Injectable Product

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 3 Days and 14 Days Post Surgery

Day 14
Change In Post Operative Pain Intensity
Change in Oral Morphine Equivalence (OME) from 3 days and 14 days post surgery

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Similar Trials

1
SIPS Operation
3
Aminocaproic acid
2
Exparel Injectable Product

Trial Design

2 Treatment Groups

Standard of Care
1 of 2
Multi-Modal
1 of 2

Active Control

Experimental Treatment

60 Total Participants · 2 Treatment Groups

Primary Treatment: Dilaudid Injectable Product · No Placebo Group · Phase 4

Multi-ModalExperimental Group · 10 Interventions: Zofran Injection, Ativan, Flexeril Oral Product, Tylenol Suspension, Marcaine Injectable Product, Hycet 7.5Mg-325Mg/15Ml Solution, Dilaudid Injectable Product, Neurontin, Scopolamine patch, Oxycodone Hydrochloride · Intervention Types: Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug
Standard of CareActiveComparator Group · 8 Interventions: Zofran Injection, Ativan, Flexeril Oral Product, Marcaine Injectable Product, Hycet 7.5Mg-325Mg/15Ml Solution, Dilaudid Injectable Product, Scopolamine patch, Oxycodone Hydrochloride · Intervention Types: Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bupivacaine
FDA approved
Gabapentin
FDA approved
Scopolamine
FDA approved
Oxycodone
FDA approved

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 3 days and 14 days post surgery

Who is running the clinical trial?

University of California, DavisLead Sponsor
855 Previous Clinical Trials
5,025,263 Total Patients Enrolled
2 Trials studying Bariatric Surgery Candidates
9,597 Patients Enrolled for Bariatric Surgery Candidates
Barbara Jachniewicz, MSN, CRNFA,Principal InvestigatorNurse Practitioner, Department of Surgery
Mohamed R Ali, MD, FACSPrincipal InvestigatorProfessor of Surgery

Eligibility Criteria

Age 35 - 65 · Female Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

Has Dilaudid Injectable Product been given the green light by the FDA?

"Dilaudid Injectable Product has been approved, so our team assigned it a safety score of 3." - Anonymous Online Contributor

Unverified Answer

Would I be eligible to participate in this trial?

"In order to be admitted into this clinical trial, applicants must possess obesity and morbidity along with being within the age bracket of 35-65. Presently, a total of 60 individuals are eligible for participation." - Anonymous Online Contributor

Unverified Answer

Could you elucidate on what research has already been conducted pertaining to Dilaudid Injectable Product?

"Currently, 265 clinical trials are actively studying the effects of Dilaudid Injectable Product. Of those in progress 60 have reached Phase 3. Boston, Massachusetts is home to many of these studies, but there are 1864 other locations hosting this medical research around the world." - Anonymous Online Contributor

Unverified Answer

For what ailment is Dilaudid Injectable Product often prescribed?

"Synovitis is typically managed with Dilaudid Injectable Product, which can also be employed to tackle ailments such as whiplash syndrome, anxiety, and ophthalmia sympathetic." - Anonymous Online Contributor

Unverified Answer

Are individuals younger than 20 years of age eligible for this experiment?

"The minimum age requirement for this trial is 35 years old and the maximum permissible age of participants is 65." - Anonymous Online Contributor

Unverified Answer

Is recruitment for this experiment still open?

"According to the clinicaltrials.gov database, enrollment is currently open for this study which was initially published on January 20th 2021 and underwent its most recent update at 11 March 2022." - Anonymous Online Contributor

Unverified Answer

How many individuals are engaged with this trial?

"Affirmative. According to clinicaltrials.gov, this medical study is actively accepting participants since its posting on January 20th 2021 and the most recent update was done in March 11th 2022; it requires 60 individuals from a single site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top